comparemela.com
Home
Live Updates
Proprietary Program - Breaking News
Pages:
Latest Breaking News On - Proprietary program - Page 1 : comparemela.com
Silence Therapeutics Highlights Recent Company Progress and Reports Third Quarter 2023 Financial Results
LONDON (BUSINESS WIRE) Nov 14, 2023
Hansoh pharma
Craig tooman
Exchange commission on
Mallinckrodt pharmaceuticals
Program updates
Corporate communications
Recent business
Proprietary program
Securities litigation reform act
Admission document
Annual report
Exchange commission
Silence therapeutics
Business wire
Silence Therapeutics Reports Second Quarter 2023 Results
Silence Therapeutics plc, Nasdaq: SLN , an experienced and innovative biotechnology company committed to transforming people’s lives by silencing diseases through precision engineered medicines,. -Today at 07:03 am- MarketScreener
Craig tooman
Hansoh pharma
Program updates
Mallinckrodt pharmaceuticals
Exchange commission on
Silence therapeutics
Chief executive officer
Recent business highlights
Proprietary program
Partnered program
Securities litigation reform act
Admission document
Annual report
Exchange commission
Investegate |Silence Therapeutics Announcements | Silence Therapeutics: Silence Provides Pipeline Updates at 2021 R&D Day
Investegate announcements from Silence Therapeutics, Silence Provides Pipeline Updates at 2021 R&D Day
New york
United states
City of
United kingdom
Giles campion
Mark rothera
Mary conway
Daniel adams gary clarence
Mallinckrodt pharmaceuticals
Exchange commission on
Investec bank
Company rd day
American society of hematology
Corporate communications
Program updates
Consilium strategic communications
vimarsana © 2020. All Rights Reserved.